Preparation and physicochemical evaluation of a new tacrolimus tablet formulation for sublingual administration

References

• Tanaka H, Kuroda A, Marusawa H, Hashimoto M, Hatanaka H, Kino T et al. (1987). Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc, 19:11–16.
   PubMed Web of Science ®Google Scholar
• Wallemacq PE, Reding R. (1993). FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clin Chem, 39:2219–2228.
   PubMed Web of Science ®Google Scholar
• Jusko WJ, Piekoszewski W, Klintmalm GB, Shaefer MS, Hebert MF, Piergies AA et al. (1995). Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther, 57:281–290.
   PubMed Web of Science ®Google Scholar
• Spencer CM, Goa KL, Gillis JC. (1997). Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs, 54:925–975.
   PubMed Web of Science ®Google Scholar
• Undre NA, Stevenson P, Schäfer A. (1999). Pharmacokinetics of tacrolimus: clinically relevant aspects. Transplant Proc, 31:21S–24S.
   PubMed Web of Science ®Google Scholar
• Sakai M, Hobara N, Hokama N, Kameya H, Ohshiro S, Sakanashi M et al. (2004). Increased bioavailability of tacrolimus after rectal administration in rats. Biol Pharm Bull, 27:1480–1482.
   PubMed Web of Science ®Google Scholar
• Visser MR, Baert L, Klooster G, Schueller L, Geldof M, Vanwelkenhuysen I et al. (2010). Inulin solid dispersion technology to improve the absorption of the BCS Class IV drug TMC240. Eur J Pharm Biopharm, 74:233–238.
   PubMed Web of Science ®Google Scholar
• Zijlstra GS, Wolting J, Prop J, Petersen AH, Hinrichs WL, Uges DR et al. (2009). Efficacy of a new pulmonary cyclosporine a powder formulation for prevention of transplant rejection in rats. J Heart Lung Transplant, 28:486–492.
   PubMed Web of Science ®Google Scholar
• Zheng X, Yang R, Zhang Y, Wang Z, Tang X, Zheng L. (2007). Part II: Bioavailability in Beagle dogs of nimodipine solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm, 33:783–789.
   PubMed Web of Science ®Google Scholar
• Kassem MA, Ridy E, Khairy LM. (1987). Pharmacokinetics of sulfisoxazole solid dispersions in rabbis. Drug Dev Ind Pharm, 13:1171–1196.
   Web of Science ®Google Scholar
• De Boer AG, De Leede LG, Breimer DD. (1984). Drug absorption by sublingual and rectal routes. Br J Anaesth, 56:69–82.
   PubMed Web of Science ®Google Scholar
• Romero I, Jiménez C, Gil F, Escuin F, Ramirez E, Fudio S et al. (2008). Sublingual administration of tacrolimus in a renal transplant patient. J Clin Pharm Ther, 33:87–89.
   PubMed Web of Science ®Google Scholar
• Srinarong P, Kouwen S, Visser MR, Hinrichs WL, Frijlink HW. (2010). Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets. Pharm Dev Technol, 15:460–468.
   PubMed Web of Science ®Google Scholar
• Srinarong P, Faber JH, Visser MR, Hinrichs WL, Frijlink HW. (2009). Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. Eur J Pharm Biopharm, 73:154–161.
   PubMed Web of Science ®Google Scholar
• de Waard H, Hinrichs WL, Visser MR, Bologna C, Frijlink HW. (2008). Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated. Int J Pharm, 349:66–73.
   PubMed Web of Science ®Google Scholar
• van Drooge DJ, Hinrichs WL, Frijlink HW. (2004). Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J Control Release, 97:441–452.
   PubMed Web of Science ®Google Scholar
• Van Drooge DJ, Hinrichs WL, Frijlink HW. (2004). Incorporation of lipophilic drugs in sugar glasses by lyophilization using a mixture of water and tertiary butyl alcohol as solvent. J Pharm Sci, 93:713–725.
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Hasumi H, Suzuki S, Kubo H, Ohtani H. (1993). Kinetic analysis of molecular interconversion of immunosuppressant FK506 by high-performance liquid chromatography. Pharm Res, 10:1785–1789.
   PubMed Web of Science ®Google Scholar
• Shah VP, Tsong Y, Sathe P, Liu JP. (1998). In vitro dissolution profile comparison–statistics and analysis of the similarity factor, f2. Pharm Res, 15:889–896.
   PubMed Web of Science ®Google Scholar
• Mishra DN, Bindal M, Singh SK, Vijaya Kumar SG. (2006). Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets. Chem Pharm Bull, 54:99–102.
   PubMed Web of Science ®Google Scholar
• Bolhuis GK, Eissens AC, Adrichem TP, Wesselingh JA, Frijlink HW. (2003). Hollow filler-binders as excipients for direct compaction. Pharm Res, 20:515–518.
   PubMed Web of Science ®Google Scholar
• Zhao N, Augsburger LL. (2006). The influence of product brand-to-brand variability on superdisintegrant Performance. A case study with croscarmellose sodium. Pharm Dev Technol, 11:179–185.
   PubMed Web of Science ®Google Scholar
• Bühler V. (2005). Polyvinylpyrrolidone excipients for the pharmaceuticals. Springer-Verlag Berlin Heidelberg.
   Google Scholar
• Park YJ, Ryu DS, Li DX, Quan QZ, Oh DH, Kim JO et al. (2009). Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulfate. Arch Pharm Res, 32:893–898.
   PubMed Web of Science ®Google Scholar
• McGregor D. (2010). Tertiary-Butanol: a toxicological review. Crit Rev Toxicol, 40:697–727.
   PubMed Web of Science ®Google Scholar
• Witschi C, Doelker E. (1997). Residual solvents in pharmaceutical products: acceptable limits, influences on physicochemical properties, analytical methods and documented values. Eur J Pharm Biopharm, 43:215–242.
   Web of Science ®Google Scholar
• Ruberg SJ, Stegeman JW. (1991). Pooling data for stability studies: testing the equality of batch degradation slopes. Biometrics, 47:1059–1069.
   PubMed Web of Science ®Google Scholar
• Moyano MA, Simionato LD, Pizzorno MT, Segall AI. (2006). Validation of a liquid chromatographic method for determination of tacrolimus in pharmaceutical dosage forms. J AOAC Int, 89:1547–1551.
   PubMed Web of Science ®Google Scholar